Literature DB >> 22270426

New laboratory procedures and Rh blood type changes in a pregnant woman.

S Gerald Sandler1, Wenping Li, Al Langeberg, Helain J Landy.   

Abstract

BACKGROUND: A woman's candidacy for Rh immune globulin depends on whether her blood type is Rh-positive (D antigen-positive) or Rh-negative (D antigen-negative). New molecular blood-typing methods have identified variant D antigens, which may be reported as Rh-positive or Rh-negative depending on the laboratory method. We describe a case illustrating the effect of the new laboratory methods on a woman's candidacy for Rh immune globulin and present recommendations for interpreting the new test results. CASE: A 40-year-old woman presented for management of her third pregnancy. During her first pregnancy, she was typed as Rh-positive ("D") and did not receive Rh immune globulin. During her second pregnancy, she was typed as Rh-negative, in accordance with revised Rh-typing procedures. Anti-D antibody was detected. During her third pregnancy, she was genotyped as a partial D antigen, which was reported as Rh-negative.
CONCLUSION: Revisions in laboratory procedures for Rh typing may present as a change in the Rh blood type of pregnant women-and as a change in their eligibility for Rh immune globulin.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22270426     DOI: 10.1097/AOG.0b013e31823f6f76

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  3 in total

1.  It's time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group.

Authors:  S Gerald Sandler; Willy A Flegel; Connie M Westhoff; Gregory A Denomme; Meghan Delaney; Margaret A Keller; Susan T Johnson; Louis Katz; John T Queenan; Ralph R Vassallo; Clayton D Simon
Journal:  Transfusion       Date:  2014-12-01       Impact factor: 3.157

2.  Phasing-in RHD genotyping.

Authors:  Willy A Flegel; Susan D Roseff; Ashok Tholpady
Journal:  Arch Pathol Lab Med       Date:  2014-05       Impact factor: 5.534

3.  RHD alleles among pregnant women with serologic discrepant weak D phenotypes from a multiethnic population and risk of alloimmunization.

Authors:  Carolina Bonet Bub; Maria Giselda Aravechia; Thiago Henrique Costa; José Mauro Kutner; Lilian Castilho
Journal:  J Clin Lab Anal       Date:  2017-04-04       Impact factor: 2.352

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.